IL98535A - Bactericidal Synergistic Preparations Containing Cephalosporin and History of Xanthine and Their Use - Google Patents

Bactericidal Synergistic Preparations Containing Cephalosporin and History of Xanthine and Their Use

Info

Publication number
IL98535A
IL98535A IL9853591A IL9853591A IL98535A IL 98535 A IL98535 A IL 98535A IL 9853591 A IL9853591 A IL 9853591A IL 9853591 A IL9853591 A IL 9853591A IL 98535 A IL98535 A IL 98535A
Authority
IL
Israel
Prior art keywords
xanthine
derivative
pharmaceutical combination
cephalosporin
methyl
Prior art date
Application number
IL9853591A
Other languages
English (en)
Hebrew (he)
Other versions
IL98535A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL98535A0 publication Critical patent/IL98535A0/xx
Publication of IL98535A publication Critical patent/IL98535A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL9853591A 1990-06-20 1991-06-17 Bactericidal Synergistic Preparations Containing Cephalosporin and History of Xanthine and Their Use IL98535A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4019571A DE4019571A1 (de) 1990-06-20 1990-06-20 Pharmazeutische kombinationspraeparate enthaltend cephalosporin- und xanthinderivate und deren verwendung

Publications (2)

Publication Number Publication Date
IL98535A0 IL98535A0 (en) 1992-07-15
IL98535A true IL98535A (en) 1996-01-19

Family

ID=6408686

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9853591A IL98535A (en) 1990-06-20 1991-06-17 Bactericidal Synergistic Preparations Containing Cephalosporin and History of Xanthine and Their Use

Country Status (26)

Country Link
US (1) US5350753A (fr)
EP (1) EP0462506B1 (fr)
JP (1) JP3213339B2 (fr)
KR (1) KR100205161B1 (fr)
CN (1) CN1057390A (fr)
AT (1) ATE144901T1 (fr)
AU (1) AU643291B2 (fr)
BR (1) BR9102554A (fr)
CA (1) CA2044977A1 (fr)
CZ (1) CZ282285B6 (fr)
DE (2) DE4019571A1 (fr)
DK (1) DK0462506T3 (fr)
ES (1) ES2093656T3 (fr)
FI (1) FI912968A (fr)
GR (1) GR3021568T3 (fr)
HR (1) HRP940708B1 (fr)
HU (1) HU212937B (fr)
IE (1) IE76290B1 (fr)
IL (1) IL98535A (fr)
MX (1) MX26309A (fr)
NO (1) NO912382L (fr)
NZ (1) NZ238580A (fr)
PT (1) PT98028B (fr)
RU (1) RU2095063C1 (fr)
YU (1) YU48415B (fr)
ZA (1) ZA914709B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1090795A (en) 1993-11-12 1995-05-29 Cell Therapeutics, Inc. Method for preventing tissue injury from hypoxia
PT812844E (pt) 1996-06-07 2003-03-31 Hoechst Ag Utilizacao de derivados de teofilina para o tratamento e profilaxia de estados de choque novos compostos de xantina e processo para a sua preparacao
JP2006510357A (ja) * 2002-11-22 2006-03-30 ザ ジョーンズ ホプキンズ ユニバーシティ 認識障害の処置のための標的
KR101315483B1 (ko) 2011-06-23 2013-10-07 주식회사 아리바이오 항생제 및 라이소포스파티딜콜린을 포함하는 면역 증강 또는 세균성 감염 질환 치료용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3817955A1 (de) * 1988-05-27 1989-11-30 Hoechst Ag Tnf-inhibitor enthaltendes arzneimittel

Also Published As

Publication number Publication date
DE59108321D1 (de) 1996-12-12
CS187891A3 (en) 1992-02-19
DE4019571A1 (de) 1992-01-02
CZ282285B6 (cs) 1997-06-11
JP3213339B2 (ja) 2001-10-02
HRP940708B1 (en) 1998-12-31
PT98028A (pt) 1992-03-31
HU912048D0 (en) 1991-12-30
BR9102554A (pt) 1992-01-21
FI912968A (fi) 1991-12-21
CA2044977A1 (fr) 1991-12-21
IL98535A0 (en) 1992-07-15
KR100205161B1 (ko) 1999-07-01
US5350753A (en) 1994-09-27
EP0462506B1 (fr) 1996-11-06
KR920000322A (ko) 1992-01-29
HU212937B (en) 1996-12-30
HUT57986A (en) 1992-01-28
FI912968A0 (fi) 1991-06-18
YU48415B (sh) 1998-07-10
EP0462506A1 (fr) 1991-12-27
IE76290B1 (en) 1997-10-08
NZ238580A (en) 1993-10-26
ZA914709B (en) 1992-03-25
AU7848291A (en) 1992-01-02
IE912107A1 (en) 1992-01-01
DK0462506T3 (da) 1996-11-25
NO912382L (no) 1991-12-23
ES2093656T3 (es) 1997-01-01
HRP940708A2 (en) 1997-02-28
GR3021568T3 (en) 1997-02-28
PT98028B (pt) 1998-11-30
CN1057390A (zh) 1992-01-01
JPH04230219A (ja) 1992-08-19
RU2095063C1 (ru) 1997-11-10
YU108291A (sh) 1995-03-27
NO912382D0 (no) 1991-06-19
ATE144901T1 (de) 1996-11-15
MX26309A (es) 1994-02-28
AU643291B2 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
CA2145078C (fr) Derives cristallin de penicilline, sa production et son utilisation
GB1221855A (en) Penicillin and cephalosporin derivatives
DK163877B (da) Analogifremgangsmaade til fremstilling af hidtil ukendte cephalosporiner
US5350753A (en) Pharmaceutical combination preparations containing cephalosporin and xanthine derivatives and their use
US3647781A (en) Imines of nitroheterocyclic aldehydes and compounds of the penicllanic acid or cepham series
AU599169B2 (en) Cephalosporin derivatives
CA1084486A (fr) DERIVES DE LA 7-.alpha.-(4-HYDROXY-1,5-NAPHTHYRIDINE-3- CARBONAMIDO)-.alpha.-PHENYLACETAMIDOCEPHALOSPORINE
IL113744A (en) History of 3-tufts and their preparation
US4874856A (en) 3-(substituted)propenyl-7-(aminothiazolylacetamido) ceph-3-em-4-carboxylic acids and esters thereof
EP0154484B1 (fr) Sel monosodique de l'acide 7-D-mandelamido-3-(1-sulfométhyltétrazol-5-yl)thiométhyl-3-céphem-4-carboxylique
Bryskier et al. Cefodizime, a new 2-aminothiazolyl cephalosporin: physicochemical properties, toxicology and structure-activity relationships
US4919932A (en) Pharmaceutical formulation for the treatment of bacterial infections
AU625559B2 (en) Pharmaceutical combination preparations and their use for the prophylaxis or treatment of bacterial infectious diseases
EP1077981B1 (fr) Nouveaux composes de cephalosporine, procedes de preparation desdits composes et compositions antimicrobiennes contenant ces composes
US3431259A (en) 7-phenylacetamidocephalosporanic acid derivatives
US4203972A (en) Penicillin composition
JPS62167784A (ja) 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
JPS54126735A (en) Bactericidal composition for medical use
ES8501768A1 (es) Procedimiento para preparar (6r, 7r)-7-( (z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oximino)-acetamido)-3-(1-piridiniometil)-cef-3-em-carboxilato x 1, 5 moles de agua, cristalizado

Legal Events

Date Code Title Description
FF Patent granted
HP Change in proprietorship
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees